INTRODUCTION
Breast cancer is the leading cause of cancer among women, with an incidence of 121.9 per 100,000 and a death rate of 22.6 per 100,000 from 2006 to 2010. 1 Mortality is substantially higher among black women than among white, Hispanic, and Asian women. 1 The effect of mammography on breast cancer mortality is controversial. Although early detection and treatment of aggressive breast cancers reduce the risk of premature mortality, 2-10 a recent Cochrane review concluded that mammograms often detect nonfatal breast cancer types and that rigorous studies did not detect a mortality benefit. 11 The Canadian National Breast Screening Study sim-ilarly detected no mortality benefit and estimated an overdiagnosis rate of 22%. 12 Appropriate breast cancer screening intervals and age of initiation are also controversial. 13, 14 Some authorities believe that overuse of mammography creates unacceptably high rates of anxiety, falsepositive detection, and morbidity as a result of unneeded procedures. [15] [16] [17] [18] Others counter that underuse causes preventable deaths. 13, 14 Before 2010, the US Preventive Services Task Force (USPSTF) recommended screening mammography every 1 to 2 years for women age 40 and older. 19 Updated USPSTF guidelines published in November 2009 recommend individual screening decisions for women age 40 to 49 years that "take patient context into account, including the patient's values regarding specific benefits and harms" and advocate screening every 2 years for women age 50 to 74 years. 15 Most other US guidelines continue to recommend mammography either annually or biennially after age 39 years, 20-24 whereas guidelines from Europe and Canada are more closely aligned with USPSTF recommendations. 25, 26 The release of the USPSTF guidelines generated major controversy and media attention 27-30 that might have affected women's attitudes about mammography and changed screening patterns. Evidence of the impact of the USPSTF recommendations is scant and mixed, with smaller studies showing either no changes 31, 32 or modest reductions in screening rates. 33, 34 We examined breast cancer screening rates before and after the 2009 guideline changes by age and race/ethnicity group in a large commercially insured population.
METHODS

Data Sources
We studied enrollment information and 2005 to 2012 administrative claims data (the Optum Clinformatics Data Mart data set; Optum, Eden Prairie, MN) 35 from a large national health plan with members in all 50 US states. We linked sociodemographic variables derived from the 2000 US census using block group code of residence. We had an ethnicity variable derived from surname analysis.
Study Population
We included commercially insured women age 40 to 64 years with at least 11 months of continuous enrollment between 2005 and 2012 and no evidence of previous mastectomy based on Current Procedural Terminology and International Classification of Diseases, Ninth Revision procedure codes (Appendix Table A1 , online only).
Outcomes
We generated quarterly and annual screening rates for all eligible women and biennial rates for women with at least 23 months of continuous enrollment. We defined women as screened for breast cancer if they had at least one mammography claim during a given interval based on Current Procedural Terminology, Healthcare Common Procedure Coding System, and International Classification of Diseases, Ninth Revision codes (Appendix Table A1 ). Similar to measures used in standardized reporting systems, such as the Healthcare Effectiveness Data and Information Set, 36 this measure comprised codes for both screening and diagnostic mammograms. We included both types because a woman who receives either is considered screened for breast cancer for the subsequent 1 to 2 years, because providers ordering such tests might not appropriately distinguish differences or might be influenced by reimbursement rates, and because policy changes can be associated with changes in coding practices. The denominator for each woman was the proportion of the quarter, calendar year, or 2-calendar year period in which she was enrolled. A woman enrolled for 21 months (out of 24) in a 2-calendar year period would have a denominator of 21/24, or 0.88, rather than 24/24, or 1.0.
Covariates and Stratifying Variables
We classified women as from predominantly white, black, or Hispanic neighborhoods if they lived in a census block group (geocoding) with at least 75% of members of the respective race/ethnicity. We classified members as having Asian or Hispanic ethnicity using surname analysis 37 and classified remaining women as from mixed-race/ethnicity neighborhoods. Geocoding is sensitive in detecting black or white race, and surname analysis provides accurate information on Asian and Hispanic ethnic group. 38 This validated approach of combining surname analysis and census data has positive and negative predictive values of approximately 80% and 90%, respectively. 38 We classified women during any given period as age 40 to 49 years or 50 to 64 years.
We removed 0.6% of eligible women because of missing geocoded values. We also classified members by the region of the country in which they resided (Northeast, South, West, and Midwest). Other covariates included age, neighborhood poverty level (classified as residence in neighborhoods with below poverty levels of Ͻ 5%, 5% to 9.9%, 10% to 19.9%, and Ն 20%), 39 and neighborhood education level (classified as residence in neighborhoods with less than high school education levels of Ͻ 15%, 15% to 24.9%, 25% to 39.9%, and Ͼ 40%). 39
Analysis
We examined sociodemographic characteristics of the populations in 2005, 2009, and 2012. We calculated quarterly, annual, and biennial mammography rates as events per person-time. Because factors such as the major recession of December 2007 to June 2009 might have affected study sample characteristics over time, we adjusted time series rates. This involved using weights derived from the 2005 population's stratum-level characteristics (education level, poverty level, race/ethnicity, and US region) applied to subsequent screening rates. We plotted mammography rates stratified by age group and race/ethnicity, standardized for the variables that were not used to stratify.
We used interrupted time-series Poisson regression with generalized estimating equations 40, 41 to fit a member-level linear model to quarterly, annual, and biennial screening trends, adjusting for member characteristics including age, region of residence, poverty level, education level, and race/ ethnicity. For the annual and biennial models, we included a 2012 and 2011 to 2012 rate term, respectively, a trend term, and the covariates mentioned earlier. For the model estimating annual rates, we excluded the years 2010 and 2011, and we excluded 2009 to 2010 and 2010 to 2011 from biennial models. The value of interest was the parameter estimate of the 2012 or 2011 to 2012 time point term; the exponential of this coefficient subtracted from 1 estimates the relative reduction in the observed 2012 rate compared with the 2012 rate as predicted by the baseline trend. We also used the recycled predictions method 42 to estimate predicted and observed 2012 and 2011 to 2012 mammography rates and absolute reductions. To confirm that mammography rate changes were coincident with the publication of the USPSTF guidelines, we performed interrupted time series analysis using the quarterly rates where the term of interest was the change in the level of screening immediately after the guidelines were published (ie, beginning in quarter 1 of 2010). To test the hypothesis that mammography rates would have reached a plateau after 2009, we performed Poisson generalized estimating equations regression to examine the difference between the estimated 2009 (2008 to 2009 for biennial) and 2012 (2011 to 2012 for biennial) mammography rates, controlling for member-level covariates. We also conducted a sensitivity analysis using a mammography measure that excluded diagnostic Current Procedural Terminology and Healthcare Common Procedure Coding System mammography codes (76090, 76091, G0204, and G0206), an approach that has a 92% positive predictive value. 43 We conducted analyses using SAS version 9.3 (SAS Institute, Cary, NC) and STATA 12.1 (StataCorp, College Station, TX). The Institutional Review Board at Harvard Pilgrim Health Care Institute (Boston, MA) approved this study. Table 1 lists the characteristics of the study populations in 2005, 2009, and 2012. The cohort comprised over 2 million women per year who had median ages of 50 to 51 years over the study period; 43% to 50% were age 40 to 49 years, and 50% to 57% were age 50 to 64 years. Approximately 60% lived in high education neighborhoods, and approximately 47% lived in low poverty neighborhoods; 3% of women were from predominantly black neighborhoods, 7% to 9% had Hispanic surnames or were from Hispanic neighborhoods, approximately 3% had Asian surnames, and 15% were from mixed-race/ ethnicity neighborhoods. Most women were from the South and Midwest United States.
RESULTS
Annual Screening Rates
Figures 1 and 2 list standardized mammography rates and show plots of these rates from 2005 to 2012. The estimated observed 2012 rate was 38.8% (95% CI, 38.6% to 39.0%; Table 2 ), whereas the predicted 2012 rate was 43.1% (95% CI, 43.1% to 43.2%), a 9.9% (95% CI, Ϫ10.4% to Ϫ9.3%) relative and 4.3% (95% CI, Ϫ4.6% to Ϫ4.1%) absolute reduction. Relative reductions were large among white, Hispanic, and Asian women (Ϫ9.4% [95% CI, Ϫ10.1% to Ϫ8.8%], Ϫ14.2% [95% CI, Ϫ15.9% to Ϫ12.5%], and Ϫ17.4% [95% CI, Ϫ20.0% to Ϫ14.8%], respectively) in this age group. Black women experienced a nonsignificant relative decrease of 2.3% (95% CI, Ϫ6.3% to 1.8%). The estimated observed and predicted 2012 mammography rates among women age 50 to 64 years were 47.5% (95% CI, 47.3% to 47.7%) and 50.7% (95% CI, 50.6% to 50.8%), respectively, a 6.1% (95% CI, Ϫ6.5% to Ϫ5.7%) relative and 3.3% (95% CI,
Ϫ3.5% to Ϫ3.0%) absolute reduction. Relative reductions were again greatest among Asian women (Ϫ11.4%; 95% CI, Ϫ14.0% to Ϫ8.7%) and not detectable among black women (Ϫ0.9%; 95% CI, Ϫ1.9% to 3.8%).
Biennial Screening Rates
Among women age 40 to 49 years, observed and predicted 2011 to 2012 biennial mammography rates were 65.8% (95% CI, 65.4% to 66.1%) and 71.9% (95% CI, 71.8% to 72.1%), respectively, a 9.0% (95% CI, Ϫ9.6% to Ϫ8.4%) relative and 6.2% (95% CI, Ϫ6.6% to Ϫ5.7%) absolute reduction. White, Hispanic, and Asian women age 40 to 49 years experienced similar relative reductions of Ϫ9.8% (95% CI, Ϫ10.5% to Ϫ9.2%), Ϫ9.2% (95% CI, Ϫ11.0% to Ϫ7.2%), and Ϫ10.6% (95% CI, Ϫ13.6% to Ϫ7.5%), respectively, whereas black women did not experience a relative reduction (Ϫ0.1%; 95% CI, Ϫ4.0% to 4.3%). Observed and predicted biennial mammography rates among women age 50 to 64 years were 76.5% (95% CI, 76.1% to 76.8%) and 81.2% (95% CI, 81.0% to 81.3%), respectively, a 6.2% (95% CI, Ϫ6.6% to Ϫ5.7%) relative and 4.7% (95% CI, Ϫ5.1% to Ϫ4.3%) absolute reduction that was similar among white, Hispanic, and Asian women. Black women age 50 to 64 years did not experience changes in biennial mammography (0.4%; 95% CI, Ϫ2.6% to 3.5%).
Quarterly interrupted time series analyses confirmed that screening rates decreased immediately after the publication of the USPSTF guidelines among women age 40 to 49 years and 50 to 64 years and in all race/ethnicity subgroups except black and Asian women age 50 to 64 years (Appendix Table A2 , online only). Our sensitivity analyses examining differences between estimated 2009 and 2012 rates showed a similar pattern of statistically significant reductions across the subgroups, but their magnitude was reduced (Appendix Table A3 , online only). Using a screening-specific mammography measure, we found increased relative effect sizes (ie, greater reductions in screening mammography after the USPSTF guideline changes; Appendix Table A4 , online only) versus our primary analysis that included any mammogram. Notable findings from our analysis of rates by region include that women age 50-64 years in the West and Midwest experienced relative reductions in biennial screening of 9.0% (95% CI, Ϫ10.3% to Ϫ7.8%; Appendix Table A5 , online only) and 10.5% (Ϫ11.4% to Ϫ9.7%), respectively.
DISCUSSION
Three years after publication of the 2009 USPSTF mammography guidelines, annual and biennial mammography rates decreased by 6% to 17% among women who were not from black or mixed-race neighborhoods. Reductions were generally larger among women age 40 to 49 years than women age 50 to 64 years, but annual rates declined to a similar degree compared with biennial rates. Changes also differed by race/ethnicity; reductions were generally greatest among Asian women and were not detectable among black women.
The differential reductions by age group and race/ethnicity could indicate some level of responsiveness to the USPSTF guidelines. The major media attention 27-30 surrounding the guidelines might have led to changes in routine clinical protocols, stimulated discussions between providers and women, or affected mammography self-referral patterns. The guidelines recommended against routine screening among women age 40 to 49 years, and reductions were greater in this Low, low-medium, high-medium, and high denotes living in neighborhoods with below poverty levels of Ͻ 5%, 5% to 9.9%, 10% to 19.9%, and Ն 20%, respectively. Please note that high denotes high poverty (ie, the poorest neighborhoods).
†See text for explanation of race/ethnicity variable. ‡High, high-medium, low-medium, and low denotes living in neighborhoods with less than high school education levels of Ͻ 15%, 15% to 24.9%, 25% to 39.9%, and Ն 40%, respectively. Please note that high denotes high education (ie, the neighborhoods with the highest levels of education). group. In addition, the USPSTF recommended that women in this age group make personalized decisions with their health care providers; black women, who have the highest risk of breast cancer mortality, 44 showed lesser reductions in mammography compared with women at lower risk.
Nevertheless, our study is unable to determine exact reasons for the patterns we detected, and it is likely that factors such as racial attitudes about cancer screening, 45 trust in consensus guidelines, previously established screening patterns, 46 ,47 physician financial incentives, 48,49 and willingness to change preventive care patterns mitigated or reinforced USPSTF recommendations after 2009.
The USPSTF guidelines are highly controversial, and it is informative to interpret results from the perspective of both USPSTF proponents and those who favor a more intense screening approach. Proponents are likely to consider decreases in screening among women age 40 to 49 years to be appropriate, or perhaps even too small, given studies suggesting population-level harms in this age group such as false-positive tests and unnecessary surgery. [15] [16] [17] [18] These proponents might also be reassured that reductions in biennial screening among women age 50 to 64 years were not large but be concerned that the reduced rates after 2009 might represent an unintended consequence that could jeopardize Healthy People 2020 mammography goals. 50 Advocates of a more intense breast cancer screening approach, as reflected in other consensus guidelines, 20-24 are likely to consider all screening reductions concerning. These advocates might consider that decades of progress in increasing screening may have been reversed.
Our findings demonstrating small to moderate decreases in mammography after 2009 are consistent with two smaller shorterterm studies that also used administrative data. Sharpe et al 34 studied older women using Medicare part B data and found a 4.3% decline in 2010 mammography versus 2009 mammography rates. A study using a Vermont mammography registry also found a larger reduction among women age 40 to 49 years (4.8%) than women age 50 to 74 years (3.0%). 33 A third study using health insurance claims data found slight trend increases in monthly mammography after the USPSTF guideline changes 51 but used a more restrictive definition of breast cancer screening that used only tests coded as screening mammograms. As mentioned earlier, we intentionally included both screening and diagnostic mammograms to provide a broad measure of population screening rates given that women are considered screened for breast cancer if they receive either a screening or diagnostic mammogram. Two studies using self-reported data found no change in mammography after 2009. Pace et al 32 found that mammography rates between 2008 and 2011 were unchanged in the 40-to 49-year and 50-to 74-year age groups. Similarly, Howard and Adams 31 detected no change between 2010 and earlier years. It is possible that the substantial media attention to and criticisms of the USPSTF guideline changes 27-30 might have differentially changed response or recall bias over time. Investigators have previously found that selfreported data overestimate cancer screening. 52 We believe that our study, comprising more than 2 million women per year, provides results generalizable to commercially insured women. The insurer whose data we studied contractually requires that all claims be submitted, so we likely have a precise estimate of screening rates. Our large sample size allowed us to generate additional insights by stratifying both by age group and race/ethnicity, demonstrating, for example, potential differential responsiveness to the guidelines.
Our study has four main limitations. We assumed that the increases in screening from 2005 to 2009 were linear and would have continued at the same rate until 2012 in the absence of the USPSTF guidelines. We cannot rule out the possibility of a nonlinear trend or other factors that could have influenced screening patterns after 2009. However, our finding of a decrease in rates immediately after publication of the USPSTF guidelines and concomitant major media coverage provides strong evidence of a causal link. 53 Furthermore, only examining rates before and after the guidelines change amounts to an uncontrolled pre-post design, which is invalid for causal inference. 53, 54 The Cochran group 54 and Shadish et al 53 recognize interrupted time series design, the approach we used, as the strongest quasi-experimental design that controls for most common threats to validity (except co-interventions). In addition, the assumption of a nonlinear flattening of trend after 2009 is also an assumption and one that might have less support given historically increasing trends in breast cancer screening. Furthermore, even presuming a flattened trend after 2009, we detected statistically significant reductions among all nonblack women, although such decreases were attenuated. The latter approach provides perhaps a lower bound on the impact of the 2009 USPSTF guidelines change. However, using a screening-specific mammography measure, we detected larger reductions after the USPSTF guideline changes (Appendix Table A4 ), which might represent an upper bound of impacts. Given that the overwhelming majority of diagnostic and screening mammograms ultimately do not lead to a breast cancer diagnosis, women undergoing either test type are effectively screened for the subsequent 1 or 2 years. As a result and because providers might not code screening mammograms correctly (especially after a policy change that might reduce revenue), 43 we believe that our primary mammography measure, which included any mammogram and is consistent with the well-established Healthcare Effectiveness Data and Information Set measure, 36 is most appropri-ate, while also leading to a more conservative estimate of the USPSTF guidelines effect compared with a screening-specific measure. Although our results should be generalizable to the commercially insured population under age 65 years given the large size of the insurer whose data we examined, this data set is associated with several limitations. We were unable to assess physician-level interventions and reimbursement rates unique to the health insurer, but it is unlikely that these differed substantially from secular patterns or that providers would be highly aware of the specific health insurer of their patients or details of how that health insurer reimburses differentially from other private health insurers. Our results may not represent patterns in populations such as the uninsured or those covered by Medicaid. Finally, our measures of race/ethnicity were not based on self-report, the gold standard, but rather on surname analysis and geocoded data. However, this classification approach has positive and negative predictive values of approximately 80% and 90%, respectively. 38 In conclusion, we found that mammography decreased among nonblack women after 2009 and in a manner mostly consistent with updated USPSTF mammography guidelines. For proponents of the guidelines, our findings imply some degree of success in promulgation of the recommendations but a need to promote biennial mammography to avoid downward trends.
Those who favor a more intense screening approach should work to promote screening in all age and demographic groups, perhaps focusing more on younger Hispanic and Asian women who experienced the largest decreases. A key future research priority will be to examine potential benefits (such as fewer false-positive tests and unnecessary surgeries) and unintended consequences (such as reduced biennial screening rates and increased breast cancer death) of the guideline changes.
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